Cargando…
Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
PURPOSE: The purpose of this study is to determine the optimal dose of proton beam therapy (PBT) in hepatocellular carcinoma (HCC) patients. MATERIALS AND METHODS: Inoperable HCC patients who had naïve, recurrent, or residual tumor to treatment were considered eligible for PBT. Patients received PBT...
Autores principales: | Kim, Tae Hyun, Park, Joong-Won, Kim, Yeon-Joo, Kim, Bo Hyun, Woo, Sang Myung, Moon, Sung Ho, Kim, Sang Soo, Koh, Young-Hwan, Lee, Woo Jin, Park, Sang Jae, Kim, Joo-Young, Kim, Dae Yong, Kim, Chang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296848/ https://www.ncbi.nlm.nih.gov/pubmed/25381830 http://dx.doi.org/10.4143/crt.2013.218 |
Ejemplares similares
-
Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2017) -
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020) -
Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
por: Kim, Tae Hyun, et al.
Publicado: (2019) -
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022) -
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)